Tutkijat / Kuopio  | Airaksinen, O(lavi) |
| Alhava, E. |
| Alhonen, L. |
| Atalay, M(ustafa) |
| Cederberg, H. |
| Dunkel, L(eo) |
| Eskelinen, M(atti) |
| Giniatullin, R. |
| Gröhn, O(lli) |
| Harno, K. |
| Hartikainen, J(aana). |
| Hartikainen, J(uha). |
| Harvima, I. |
| Hiltunen, M(ikko) |
| Jääskeläinen, J(uha) E. |
| Jäkälä, P(ekka) |
| Jänne, J. |
| Jantunen, E(sa) |
| Järvinen, R. |
| Julkunen, P. |
| Kaikkonen, M(inna) U. |
| Kauhanen, J(ussi) |
| Kivipelto, M(iia) |
| Koistinaho, M. |
| Koivisto, T(imo) |
| Kokki, H. |
| Könönen, M. |
| Kosma, V(eli)-M(atti) |
| Kröger, H. |
| Kurl, S(udhir) |
| Kuusisto, J(ohanna) |
| Laakso, M(arkku) |
| Lakka, T(imo) A. |
| Lapinlampi, N(iina) |
| Laukkanen, J(ari) (UEF/KSSHP) |
| Levonen, A(nna)-L(iisa) |
| Lindgren, A(ntti) E. |
| Löppönen, H(eikki) |
| Mannermaa, A. |
| Manninen, H. |
| Mecklin, J(ukka)-P(ekka) |
| Moilanen, L(eena) |
| Mönkkönen, J. |
| Mykkänen, H. |
| Nuutinen, J. |
| Paajanen, H. |
| Paananen, J. |
| Palvimo, J.J. |
| Pelkonen, J(ukka) |
| Pihlajamäki, J(ussi) |
| Pihlajamäki, M. |
| Pitkänen, A(sla) |
| Punnonen, K. |
| Raatikainen K |
| Rauramaa, R. |
| Rissanen, T.T. |
| Roine, R(isto) P. |
| Ryynänen, O.P. |
| Saarikoski, S. |
| Schwab, U(rsula) |
| Sivenius, J. |
| Soininen, H(ilkka) |
| Soininen, P(asi) |
| Sorri, I. |
| Stancakova, A(lena) |
| Sulkava, R. |
| Sund, R(eijo) |
| Tammi, M. |
| Tanila, H(eikki) |
| Tiihonen, J(ari) |
| Uusaro, A. |
| Uusitupa, M. |
| Vanninen, R. |
| Vaskilampi, T. |
| Viinamäki, H(eimo) |
| Virtanen, M(arianna) |
| Voutilainen, R(aimo) |
| Voutilainen, S(ari) |
| Wahlfors, J. |
| Wirth, T. |
| Wong, G. |
| Ylä-Herttuala, S(eppo) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | Presynaptic Vesicle Protein SEPTIN5 Regulates the Degradation of APP C-Terminal Fragments and the Levels of Aβ. | Hiltunen, M(ikko) | 340 days | save |  |  | |
| Diabetic phenotype in mouse and humans reduces the number of microglia aroundβ-amyloid plaques. | Hiltunen, M(ikko) | 349 days | save | | | |
| Alzheimer's genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner. | Hiltunen, M(ikko) | 355 days | save | | | |
| BV-2 Microglial Cells Overexpressing C9orf72 Hexanucleotide Repeat Expansion Produce DPR Proteins and Show Normal Functionality but No RNA Foci. | Hiltunen, M(ikko) | 360 days | save | | | |
| PTPR type Q in cerebrospinal fluid reflects ependymal cells dysfunction and is a potential biomarker for adult chronic hydrocephalus. | Hiltunen, M(ikko) | 381 days | save | | | |
| Diabetes is associated with familial idiopathic normal pressure hydrocephalus: a case-control comparison with family members. | Hiltunen, M(ikko) | 404 days | save | | | |
| Mutation Analysis of the Genes Associated with Parkinson's Disease in a Finnish Cohort of Early-Onset Dementia. | Hiltunen, M(ikko) | 490 days | save | | | |
| Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease. | Hiltunen, M(ikko) | 631 days | save | | | |
| In Vitro and In Vivo Pipeline for Validation of Disease-Modifying Effects of Systems Biology-Derived Network Treatments for Traumatic Brain Injury-Lessons Learned. | Hiltunen, M(ikko) | 724 days | save | | | |
| C9orf72 Proteins Regulate Autophagy and Undergo Autophagosomal or Proteasomal Degradation in a Cell Type-Dependent Manner. | Hiltunen, M(ikko) | 727 days | save | | | |
| Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients. | Hiltunen, M(ikko) | 758 days | save | | | |
| Supervised pathway analysis of blood gene expression profiles in Alzheimer's disease. | Hiltunen, M(ikko) | 771 days | save | | | |
| Predicting Development of Alzheimer's Disease in Patients with Shunted Idiopathic Normal Pressure Hydrocephalus. | Hiltunen, M(ikko) | 777 days | save | | | |
| L-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia. | Hiltunen, M(ikko) | 779 days | save | | | |
| Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. | Hiltunen, M(ikko) | 801 days | save | | | |
| Maintenance of High Genome Integrity over Vegetative Growth in the Fairy-Ring Mushroom Marasmius oreades. | Hiltunen, M(ikko) | 804 days | save | | | |
| Using online game-based platforms to improve student performance and engagement in histology teaching. | Hiltunen, M(ikko) | 824 days | save | | | |
| Altered Insulin Signaling in Alzheimer's Disease Brain - Special Emphasis on PI3K-Akt Pathway. | Hiltunen, M(ikko) | 843 days | save | | | |
| Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS. | Hiltunen, M(ikko) | 875 days | save | | | |
| Mutation Analysis of the Genes Linked to Early Onset Alzheimer's Disease and Frontotemporal Lobar Degeneration. | Hiltunen, M(ikko) | 881 days | save | | | |
| BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation. | Hiltunen, M(ikko) | 901 days | save | | | |
| Prevalence of C9ORF72 Expansion in a Large Series of Patients with Idiopathic Normal-Pressure Hydrocephalus. | Hiltunen, M(ikko) | 958 days | save | | | |
| Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. | Hiltunen, M(ikko) | 969 days | save | | | |
| PIB PET Is Associated with the Brain Biopsy Amyloid-β Load in Subjects Examined for Normal Pressure Hydrocephalus. | Hiltunen, M(ikko) | 1001 days | save | | | |
| Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer's Disease. | Hiltunen, M(ikko) | 1021 days | save | | | |
| Copy number loss in SFMBT1 is common among Finnish and Norwegian patients with iNPH. | Hiltunen, M(ikko) | 1034 days | save | | | |
| A multiomic approach to characterize the temporal sequence in Alzheimer's disease-related pathology. | Hiltunen, M(ikko) | 1043 days | save | | | |
| Intranasal insulin activates Akt2 signaling pathway in the hippocampus of wild-type but not in APP/PS1 Alzheimer model mice. | Hiltunen, M(ikko) | 1044 days | save | | | |
| Decreased plasma C-reactive protein levels in APOEε4 allele carriers. | Hiltunen, M(ikko) | 1098 days | save | | | |
| Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers. | Hiltunen, M(ikko) | 1106 days | save | | | |
| Alterations in mitochondria-endoplasmic reticulum connectivity in human brain biopsies from idiopathic normal pressure hydrocephalus patients. | Hiltunen, M(ikko) | 1119 days | save | | | |
| Protein kinase C -activating isophthalate derivatives mitigate Alzheimer's disease-related cellular alterations. | Hiltunen, M(ikko) | 1159 days | save | | | |
| A report from the 8th Kuopio Alzheimer Symposium. | Hiltunen, M(ikko) | 1166 days | save | | | |
| Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation. | Hiltunen, M(ikko) | 1167 days | save | | | |
| Melatonin receptor type 1A gene linked to Alzheimer's disease in old age. | Hiltunen, M(ikko) | 1204 days | save | | | |
| Associations of Genetic Susceptibility to Alzheimer's Disease with Adiposity and Cardiometabolic Risk Factors among Children in a 2-Year Follow-up Study. | Hiltunen, M(ikko) | 1224 days | save | | | |
| S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies. | Hiltunen, M(ikko) | 1237 days | save | | | |
| Prevalence of Schizophrenia in Idiopathic Normal Pressure Hydrocephalus. | Hiltunen, M(ikko) | 1265 days | save | | | |
| Interrelationship between the Levels of C9orf72 and Amyloid-β Protein Precursor and Amyloid-β in Human Cells and Brain Samples. | Hiltunen, M(ikko) | 1349 days | save | | | |
| Incidence, comorbidities, and mortality in idiopathic normal pressure hydrocephalus. | Hiltunen, M(ikko) | 1366 days | save | | | |
| Behavioral testing of mice exposed to intermediate frequency magnetic fields indicates mild memory impairment. | Hiltunen, M(ikko) | 1420 days | save | | | |
| PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease. | Hiltunen, M(ikko) | 1435 days | save | | | |
| DHCR24 exerts neuroprotection upon inflammation-induced neuronal death. | Hiltunen, M(ikko) | 1447 days | save | | | |
| Genetic risk factors in Finnish patients with Parkinson's disease. | Hiltunen, M(ikko) | 1470 days | save | | | |
| Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants. | Hiltunen, M(ikko) | 1480 days | save | | | |
| Alzheimer's Disease-Related Polymorphisms in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus. | Hiltunen, M(ikko) | 1480 days | save | | | |
| Abstracts from Hydrocephalus 2016. | Hiltunen, M(ikko) | 1496 days | save | | | |
| Molecular Epidemiology of Charcot-Marie-Tooth Disease in Northern Ostrobothnia, Finland: A Population-Based Study. | Hiltunen, M(ikko) | 1531 days | save | | | |
| Disease-modifying effect of atipamezole in a model of post-traumatic epilepsy. | Hiltunen, M(ikko) | 1550 days | save | | | |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. | Hiltunen, M(ikko) | 1561 days | save | | | |
| | 
report | next » | | |
|
